Citation tools
"Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen–Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide." Journal of Nuclear Medicine
62.10
(2021):
1430-1437.
Web. 18 Mar. 2025.